4.5 Article

Distribution of m1 muscarinic acetylcholine receptors in the hippocampus of patients with Alzheimer's disease and dementia with Lewy bodies - an immunohistochemical study

Journal

JOURNAL OF THE NEUROLOGICAL SCIENCES
Volume 193, Issue 1, Pages 23-28

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/S0022-510X(01)00638-4

Keywords

muscarinic acetylcholine receptor; subtype-specific antibody; immunohistochemistry; Alzheimer's disease; dementia with Lewy bodies

Ask authors/readers for more resources

Of the five subtypes (m1-m5) of muscarinic acetylcholine receptors (mAChR), the ml subtype is the most abundant in the human cerebral cortex and hippocampus. Impairment of the muscarinic cholinergic system in the brain may cause cognitive dysfunction in patients with Alzheimer's disease (AD), and choline esterase inhibitors (ChE-1) are used to improve cognitive dysfunction. Severe impairment of the cholinergic system has also been reported in the brains of subjects with dementia with Lewy bodies (DLB), There have been a few reports about the distribution of mAChR subtypes in the human brain. In the present study, we investigated the distribution of ml mAChR in the human hippocampus using an antibody against the ml subtype. In the control brains, m1 immunoreactivity was observed in the apical dendrites and cell bodies of granular neurons of the dentate gyrus and pyramidal neurons of CAI-3 and the subiculum. The dendrites and the cell bodies of the pyramidal neurons in layers III and V of the parahippocampal cortex and other temporal cortices were also positive for m1 immunoreactivity. This ml immunoreactivity was markedly reduced in AD and DLB brains. (C) 2001 Elsevier Science B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available